4
Changes in Ownership
NOVAVAX INC Filed Acc 0001209191-21-062976
President, R&D sold 8,250 shares at an average $183.82 ($1,516,552)
- President, R&D acquired 8,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Glenn Gregory M · President, R&D
Table I: Non-derivative
18 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-02 | Exercise or conversion : show line 1 in the form | +8,250 | $19.08 | $157,410 | 12,311 | D |
| 2021-11-02 | Sale : show line 2 in the form | −600 | $177.12 | $106,269 | 11,711 | D |
| 2021-11-02 | Sale : show line 3 in the form | −1,200 | $178.12 | $213,749 | 10,511 | D |
| 2021-11-02 | Sale : show line 4 in the form | −900 | $179.09 | $161,180 | 9,611 | D |
| 2021-11-02 | Sale : show line 5 in the form | −600 | $180.41 | $108,248 | 9,011 | D |
| 2021-11-02 | Sale : show line 6 in the form | −670 | $181.55 | $121,637 | 8,341 | D |
| 2021-11-02 | Sale : show line 7 in the form | −600 | $182.58 | $109,547 | 7,741 | D |
| 2021-11-02 | Sale : show line 8 in the form | −800 | $183.58 | $146,860 | 6,941 | D |
| Open-market sales · 8,250 sh · avg $183.82 · $1,516,552 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-11-02 | Exercise or conversion : show line 19 in the form Stock Option (Right to Buy) | −8,250 | $19.08 | 2030-04-17 | 8,250 | 123,750 | D |
Loading xslF345X03/doc4.xml…